Theravance Biopharma, Inc. Increase (Decrease) in Accounts Payable
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Accounts Payable of -$1.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$448.00K.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.47M, a 984.34% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $355.00K, a 54.95% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $538.00K.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2025 was $326.00K, a 56.53% decline from fiscal 2024.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2024 was $750.00K, a 12400.00% increase from fiscal 2023.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2023 was $6.00K.
- Theravance Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.61M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$448.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.92M 10-Q · filed 2026-08-11 | -$1.56M derived: sum of 3 quarters · filed 2026-08-11 | -$1.02M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$1.47M 10-Q · filed 2026-05-07 | -$1.11M derived: sum of 2 quarters · filed 2026-05-07 | -$575.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.31M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $893.00K derived: sum of 2 quarters · filed 2026-03-23 | $160.00K derived: sum of 3 quarters · filed 2026-08-11 | $326.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $538.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$195.00K derived: sum of 2 quarters · filed 2026-08-11 | -$29.00K 10-Q · filed 2025-11-12 | $759.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$733.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$567.00K 10-Q · filed 2026-08-11 | $221.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $166.00K 10-Q · filed 2026-05-07 | $954.00K derived: sum of 2 quarters · filed 2026-05-07 | $734.00K derived: sum of 3 quarters · filed 2026-05-07 | $732.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $568.00K derived: sum of 2 quarters · filed 2026-03-23 | $566.00K derived: sum of 3 quarters · filed 2026-03-23 | $750.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$222.00K derived: sum of 2 quarters · filed 2025-11-12 | -$38.00K 10-Q · filed 2025-11-12 | -$386.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $182.00K 10-Q · filed 2025-08-13 | -$166.00K derived: sum of 3 quarters · filed 2025-08-13 | $105.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $184.00K 10-Q · filed 2025-05-12 | -$164.00K derived: sum of 2 quarters · filed 2025-05-12 | $107.00K derived: sum of 3 quarters · filed 2025-05-12 | -$812.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$77.00K derived: sum of 2 quarters · filed 2025-03-07 | -$996.00K derived: sum of 3 quarters · filed 2025-03-07 | $6.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$648.00K derived: sum of 2 quarters · filed 2024-11-14 | $354.00K 10-Q · filed 2024-11-14 | -$3.41M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $83.00K 10-Q · filed 2024-08-08 | -$3.68M derived: sum of 3 quarters · filed 2024-08-08 | -$1.50M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-15 | -$2.76M derived: sum of 2 quarters · filed 2024-05-15 | -$584.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.01M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$1.59M derived: sum of 2 quarters · filed 2024-03-01 | $7.00K derived: sum of 3 quarters · filed 2024-03-01 | -$1.61M 10-K · filed 2024-03-01 |
| 2022-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.77M derived: sum of 2 quarters · filed 2023-11-09 | $2.15M 10-Q · filed 2023-11-09 | -$3.59M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$26.00K 10-Q · filed 2023-08-09 | -$5.77M derived: sum of 3 quarters · filed 2023-08-09 | -$7.59M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.62M 10-Q · filed 2023-05-10 | -$7.36M derived: sum of 2 quarters · filed 2023-05-10 | -$9.18M derived: sum of 3 quarters · filed 2023-05-10 | -$4.08M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$7.56M derived: sum of 2 quarters · filed 2023-03-01 | -$2.46M derived: sum of 3 quarters · filed 2023-03-01 | -$3.53M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.28M derived: sum of 2 quarters · filed 2022-11-09 | $2.21M 10-Q · filed 2022-11-09 | $3.73M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.03M 10-Q · filed 2022-08-08 | $5.55M derived: sum of 3 quarters · filed 2023-03-01 | $1.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$1.07M 10-Q · filed 2022-05-06 | $452.00K derived: sum of 2 quarters · filed 2023-03-01 | -$3.43M derived: sum of 3 quarters · filed 2023-03-01 | $1.43M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.35M derived: sum of 2 quarters · filed 2023-03-01 | $2.50M derived: sum of 3 quarters · filed 2023-03-01 | $3.66M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $979.00K derived: sum of 2 quarters · filed 2021-11-08 | $2.13M 10-Q · filed 2021-11-08 | -$1.60M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.01M 10-Q · filed 2021-08-05 | $2.28M derived: sum of 3 quarters · filed 2022-02-28 | $7.23M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.15M 10-Q · filed 2021-05-06 | -$2.58M derived: sum of 2 quarters · filed 2022-02-28 | $2.37M derived: sum of 3 quarters · filed 2022-02-28 | $320.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.22M derived: sum of 2 quarters · filed 2022-02-28 | -$834.00K derived: sum of 3 quarters · filed 2022-02-28 | -$4.27M 10-K · filed 2022-02-28 |
| 2019-09-30 | $4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.90M derived: sum of 2 quarters · filed 2020-11-09 | -$543.00K 10-Q · filed 2020-11-09 | $4.70M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$5.49M 10-Q · filed 2020-08-10 | -$251.00K derived: sum of 3 quarters · filed 2021-02-26 | $395.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$3.44M 10-Q · filed 2020-05-08 | $1.80M derived: sum of 2 quarters · filed 2021-02-26 | $2.45M derived: sum of 3 quarters · filed 2021-02-26 | $584.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $5.89M derived: sum of 2 quarters · filed 2021-02-26 | $4.02M derived: sum of 3 quarters · filed 2021-02-26 | $3.58M 10-K · filed 2021-02-26 |
| 2018-09-30 | $646.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$1.22M derived: sum of 2 quarters · filed 2019-11-08 | -$1.67M 10-Q · filed 2019-11-08 | -$1.41M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$2.31M 10-Q · filed 2019-08-05 | -$2.06M derived: sum of 3 quarters · filed 2020-02-27 | -$3.31M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$449.00K 10-Q · filed 2019-05-10 | -$193.00K derived: sum of 2 quarters · filed 2020-02-27 | -$1.45M derived: sum of 3 quarters · filed 2020-02-27 | $1.34M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$1.00M derived: sum of 2 quarters · filed 2020-02-27 | $1.79M derived: sum of 3 quarters · filed 2020-02-27 | $3.80M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.54M derived: sum of 2 quarters · filed 2018-11-08 | $3.54M 10-Q · filed 2018-11-08 | -$58.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $4.80M 10-Q · filed 2018-08-02 | $1.20M derived: sum of 3 quarters · filed 2019-02-28 | -$881.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $2.00M 10-Q · filed 2018-05-09 | -$1.59M derived: sum of 2 quarters · filed 2019-02-28 | -$3.67M derived: sum of 3 quarters · filed 2019-02-28 | -$4.98M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$5.68M derived: sum of 2 quarters · filed 2019-02-28 | -$6.99M derived: sum of 3 quarters · filed 2019-02-28 | -$16.44M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$3.39M derived: sum of 2 quarters · filed 2017-11-08 | -$12.84M 10-Q · filed 2017-11-08 | -$632.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$10.76M 10-Q · filed 2017-08-09 | $1.45M derived: sum of 3 quarters · filed 2018-02-28 | $1.73M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$9.45M 10-Q · filed 2017-05-10 | $2.76M derived: sum of 2 quarters · filed 2018-02-28 | $3.04M derived: sum of 3 quarters · filed 2018-02-28 | $4.70M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $12.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $12.49M derived: sum of 2 quarters · filed 2018-02-28 | $14.15M derived: sum of 3 quarters · filed 2018-02-28 | $8.72M 10-K · filed 2018-02-28 |
| 2015-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.94M derived: sum of 2 quarters · filed 2016-11-09 | -$3.49M 10-Q · filed 2016-11-09 | $920.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$3.77M 10-Q · filed 2016-08-09 | $639.00K derived: sum of 3 quarters · filed 2017-03-01 | -$2.27M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$5.43M 10-Q · filed 2016-05-10 | -$1.02M derived: sum of 2 quarters · filed 2017-03-01 | -$3.93M derived: sum of 3 quarters · filed 2017-03-01 | -$420.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.50M derived: sum of 2 quarters · filed 2017-03-01 | $5.01M derived: sum of 3 quarters · filed 2017-03-01 | $3.92M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $602.00K derived: sum of 2 quarters · filed 2015-11-12 | -$492.00K 10-Q · filed 2015-11-12 | -$277.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $2.41M 10-Q · filed 2015-08-13 | $2.63M derived: sum of 3 quarters · filed 2016-03-11 | $3.71M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$1.09M 10-Q · filed 2015-05-13 | -$879.00K derived: sum of 2 quarters · filed 2016-03-11 | $208.00K derived: sum of 3 quarters · filed 2016-03-11 | $1.17M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.30M derived: sum of 2 quarters · filed 2016-03-11 | $2.26M derived: sum of 3 quarters · filed 2016-03-11 | $2.11M 10-K · filed 2016-03-11 |
| 2013-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.05M derived: sum of 2 quarters · filed 2014-11-12 | $1.90M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $961.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $811.00K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$150.00K 10-Q · filed 2014-06-24 | |||
| 2012-12-31 | -$1.53M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |